Hull & East Yorkshire Hospitals NHS Trust
Hull, HU3 2RW, United Kingdom
NCT Number: NCT01118598
Niacin will improve postprandial hyperlipidaemia and cardiovascular risks indices via its lipid lowering as well as via pleiotropic effects in patients with polycystic ovary syndrome (PCOS).
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 4
Hull, HU3 2RW, United Kingdom
Polycystic ovary syndrome is a common hormone problem in young women and, as a result of it, they can experience irregular periods, reduced fertility, acne and increased body hair. Frequently, increased weight is a feature. Research suggests that they could have a higher risk of diabetes, high cholesterol and cardiovascular disease such as high blood pressure, angina, heart attack and stroke.
The fat from the diet is transported from the stomach into the blood and then taken up by the liver, muscles and fat tissues to store or use as an energy source. Delayed removal of fat from the circulation resulting rise of fat after a meal has been known to happen in PCOS. High fats after a meal are a strong risk factor for cardiovascular disease.
Niacin has been in clinical use to lower bad cholesterol and to increase good cholesterol for many years. It has been proved to be effective in reducing risks of heart disease in patients with diabetes. However the effect of niacin on reducing cardiovascular risks and reducing fat level after a meal in PCOS has not been studied and this is why we plan to do this research.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
tablet of nicotinic acid 1000 mg/laropiprant 20 mg one tablet of for 4 weeks followed by two tablets od for 8 weeks
Other names: tredaptive
placebo tablet one a day for first 4 weeks followed by two a day for 8 weeks
Time frame: 3 months
Postprandial triglyceride will be measured using meal test.
Time frame: 3 months
Time frame: 3 months
Peripheral arterial tone (PAT- index) will be measured using ENDO PAT 2000 before and after intervention
Hull University Teaching Hospitals NHS Trust
Other Gov
To Determine if the Cardiovascular Risk Indices Including Postprandial Hypertriglyceridaemia Are Modified Favourably by Nicotinic Acid (Niacin) in Patients With Polycystic Ovary Syndrome ( PCOS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585396
Adnexal Diseases, Cysts
Cairo, Egypt
View Trial DetailsNCT07635082
Adnexal Diseases, Cysts
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
View Trial DetailsNCT04120597
Adnexal Diseases, Cysts
Nanchang, Jiangxi, China
View Trial DetailsNCT07604870
Adnexal Diseases, Body Weight
Elâzığ, Turkey (Türkiye)
View Trial Details